Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
135 participants
OBSERVATIONAL
2007-03-13
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.
NCT06597292
Phase III Presbyopia Correction Using the VIS Opti-K™ System
NCT06487897
Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
NCT01028937
Using the VisuMax Femtosecond Laser System to Perform SMILE Optimized for Presbyopia by Modulation of Postoperative Spherical Aberration
NCT05684237
Trial of the PresVIEW Implant for the Improvement of Near Vision in Patients With Presbyopia
NCT01166568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
\-
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VIS, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J Berry, PhD
Role: PRINCIPAL_INVESTIGATOR
VIS, Inc.
Related Links
Access external resources that provide additional context or updates about the study.
VIS, Inc website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VIS Opti-K-Presbyopia #002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.